Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with kawasaki syndrome complicated by coronary artery disease

Pediatric Research

Volumn 42, Issue 3, 1997, Pages 268-272

  Leung, Donald Y M ^a,b   Sullivan, Kathleen E ^f   Brown Whitehorn, Terri F ^f   Fehringer, Amy P ^a   Allen, Steven ^d   Finkel, Terri H ^a   Washington, Reginald L ^c   Makida, Ryuji ^a   Schlievert, Patrick M ^e  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c PRESBYTERIAN ST LUKE S MEDICAL CENTER   (United States)

^d Wichita Clinic   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

EXFOLIATIN; STAPHYLOCOCCUS TOXIN;

ARTICLE; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY DISEASE; HUMAN; IMMUNOPATHOGENESIS; INFANT; LYMPHOCYTE SUBPOPULATION; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE ACTIVATION; TOXIN SYNTHESIS;

EID: 0030795445     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199709000-00004     Document Type: Article

References (26)

1. Tizard EJ, Baguley E, Hughes GR, Dillon MJ 1991 Antiendothelial cell antibodies detected by a cellular based ELISA in Kawasaki disease. Arch Dis Child 66:189-192
2. Meissner HC, Leung DYM 1995 Kawasaki syndrome. Curr Opin Rheumatol 7:455-458
3. Suzuki A, Kamiya T, Kuwahara N, Ono Y, Kohata T, Takahashi O, Kimura K, Tukamiya M 1986 Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr Cardiol 7:3-9
4. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP, Mason WH, Meissner HC, Rowley AH, Shulman ST, Reddy V, Sundel RP, Wiggins JW, Colton T, Melish ME, Rosen FS 1991 A single intravenous infusion of γ globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633-1639
5. Rowley AH, Gonzalez-Crussi F, Gidding SS 1987 Incomplete Kawasaki disease with coronary artery involvement. J Pediatr 110:409-413
6. Leung DYM, Meissner HC, Fulton DR, Quimby F, Schlievert PM 1995 Superantigens in Kawasaki disease. Clin Immunol Immunopathol 77:119-126
7. Abe Y, Nakano S, Nakahar T, Kamezawa Y, Kato I, Ushijima H, Yoshino K, Ito S, Noma S, Okitsu S, Tujima M 1990 Detection of serum antibody by the antimitogen assay against streptococcal erythrogenic toxins. Pediatr Res 27:11-15
8. Terai M, Miwa K, Williams T, Kabat W, Fukuyama M, Okajima Y, Igarashi H, Shulman ST 1995 The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J Infect Dis 172:558-561
9. Todome Y, Ohkuni H, Mizuse M, et al. 1995 Superantigenic exotoxin production by isolates of Staphylococcus aureus from the Kawasaki syndrome patients and age-matched control children. J Med Microbiol 42:91-95
10. Leung DYM, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM 1993 Toxic shock syndrome toxin-secreting Staphylococccus aureus in Kawasaki syndrome. Lancet 342:1385-1388
11. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung DYM 1992 Selective expansion of T cells expressing T cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc Natl Acad Sci USA 89:4066-4070
12. Abe J, Kotzin BL, Meissner C, Melish ME, Takahashi M, Fulton D, Romagne F, Malissen B, Leung DYM 1993 Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med 177:791-796
13. Curtis N, Zheng R, Lamb JR, Levin M 1995 Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child 72:308-311
14. Leung DYM, Giorno R, Kazemi LV, Flynn PA, Bussel JB 1995 Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. J Immunol 155:5018-5021
15. + T cells in the small intestinal mucosa in Kawasaki disease. Pediatr Res 39:264-266
16. American Heart Association Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease 1990 Diagnostic guidelines for Kawasaki disease. JAMA 44:1218-1219
17. Schlievert PM, Osterholm MT, Kelly JA, Nishimura RD 1982 Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome. Ann Intern Med 96:937-940
18. Schlievert PM 1988 Immunochemical assays for toxic shock syndrome toxin-1. Methods Enzymol 165:339-344
19. Kotzin BL, Leung DYM, Kappler J, Marrack P 1993 Superantigens and their potential role in human disease. Adv Immunol 54:99-166
20. Burns JC, Wiggins JW, Toews WH, Newburger JW, Leung DYM, Wilson H, Glode MP 1986 The clinical spectrum of Kawasaki syndrome in infants less than six months of age. J Pediatr 109:759-763
21. Matsubara T, Furukawa S, Yabuta K. 1990. Serum levels of tumor necrosis factor, interleukin 2 receptor and interferon-γ in Kawasaki disease involved coronary artery lesions. Clin Immunol Immunopathol 56: 29-36
22. McCormack JE, Callahan JE, Kappler J, Marrack PC 1993 Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J Immunol 150:3785-3792
23. Leung DYM, Gately M, Trumble A, Ferguson-Darnell B, Schlievert PM, Picker LJ 1995 Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen (CLA). J Exp Med 181:747-753
24. Pietra BA, De Inocencio J, Giannini EH, Hirsch R 1994 TCR Vβ family repertoire and T cell activation markers in Kawasaki disease. J Immunol 153:1881-1888
25. Wiesenthal AM, Todd JK 1984 Toxic shock syndrome in children aged 10 years or less. Pediatrics 74:112-117
26. Gamillscheg A, Zobel G, Karpf EF, Dacar D, Beitxke A, Stein JI, Suppan C 1993 Atypical presentation of Kawasaki disease in an infant. Pediatr Cardiol 14:223-226